search
Back to results

Reduce Nonsteroidal Antiinflammatory Drugs Doses for Analgesia After Sternotomy (LoDoNSAID)

Primary Purpose

Cardiac Surgery, Post-operative Pain

Status
Unknown status
Phase
Phase 2
Locations
France
Study Type
Interventional
Intervention
Ketoprofen
Sponsored by
University Hospital, Clermont-Ferrand
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cardiac Surgery focused on measuring Cardiac surgery, Post-operative pain, Kétoprofène, Minimum analgesic dose, Morphin consumption, Morphin secondary effects, Patient comfort and satisfaction, Renal fonction

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients scheduled for a cardiac surgery (Coronary artery bypass graft, valve replacement)
  • Age over 18 years
  • Weight between 60 and 100 kg
  • Absence of criteria for non-inclusion

Exclusion Criteria:

  • Age over 75 years
  • Renal insufficiency (MDRD <60 ml / min)
  • Hepatic Insufficiency
  • Congestive heart failure (EF <40%)
  • Insulin-requiring diabetes
  • Preoperative coagulation trouble
  • History of peptic ulcer or gastrointestinal bleeding
  • Allergy to NSAIDs
  • Surgery in emergency, aorta surgery, heart transplantation
  • Peptic ulcer scalable, history of peptic ulcer or recurrent bleeding (2 or more distinct episodes of bleeding or ulceration objectified)
  • Pregnant or lactating women
  • Major protected

Sites / Locations

  • CHU de Clermont-FerrandRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Placebo Comparator

Other

Other

Other

Arm Label

placebo group

ketopofen quarter dose

ketoprofen half-dose

Ketoprofen full dose

Arm Description

Group 1 : Placebo group (P). 0 mg/kg ketoprofen IV every 6 hours for 48 hours (or 0 mg/kg every 24 hours) for 48 hours

Group 2 : "Ketoprofen quarter dose" (K ¼). 0,125 mg/kg ketoprofen IV every 6 hours (0,5 mg/kg every 24 hours) for 48 hours.

Group 3 : "Ketoprofen half-dose" (K ½). 0,25 mg/kg ketoprofen IV every 6 hours (1 mg/kg every 24 hours) for 48 hours.

Group 4 : "Ketoprofen full dose" (KPD). 0,5 mg/kg ketoprofen IV every 6 hours (or 2 mg/kg every 24 hours) for 48 hours

Outcomes

Primary Outcome Measures

Pain at the mobilization
Pain at the mobilization of the first 48 hours postoperatively, measured every 4 hours by simple numerical scale or VAS (0: no pain to 10: unbearable pain)

Secondary Outcome Measures

Demographic criteria
Quantity of sufentanil administered intraoperatively
Pain at rest measured by Visual Analogue Scale
Pain at rest measured every 4 hours from H0+4 hours to H+48 hours by Visual Analogue Scale (H0 : sedation stop time, 1 hour before waking)
Total morphine consumption
Blood gas monitoring 3 times a day
Time of removal of drains after surgery
Resumption of transit characterized by the first gas time after surgery.
Nausea occurrence (number of episodes) assessed every 4 hours
Vomiting occurrence (number of episodes) assessed every 4 hours
Effective Duration of stay in the Intensive Care Unit
Patient satisfaction for its first mobilization assessed by simple scale Likert
Occurrence of the following complications: Renal respiratory cardiac Neurological infectious Hemorrhagic
Any readmission to the intensive care unit in the two weeks following the surgery

Full Information

First Posted
July 1, 2014
Last Updated
July 1, 2014
Sponsor
University Hospital, Clermont-Ferrand
search

1. Study Identification

Unique Protocol Identification Number
NCT02180087
Brief Title
Reduce Nonsteroidal Antiinflammatory Drugs Doses for Analgesia After Sternotomy
Acronym
LoDoNSAID
Official Title
Reduce Nonsteroidal Antiinflammatory Drugs Doses for Analgesia After Sternotomy
Study Type
Interventional

2. Study Status

Record Verification Date
July 2014
Overall Recruitment Status
Unknown status
Study Start Date
February 2014 (undefined)
Primary Completion Date
August 2015 (Anticipated)
Study Completion Date
September 2015 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Clermont-Ferrand

4. Oversight

5. Study Description

Brief Summary
Currently, the management of pain after cardiac surgery is based on the concept of multimodal analgesia: Combined use of non-opioid analgesics associated with morphine intravenous analgesia by a system controlled by the patient (patient-controlled analgesia-PCA). The combination of paracetamol and morphine PCA is very effective on pain at rest, but is limited on pain mobilization and causes the problem of side effects associated with opioid (overdose, sedation, respiratory depression, gastrointestinal intolerance, urinary retention ...) which are contributing factors to increase the length of stay in Intensive Care Unit, an additional cost of care and an increase postoperative morbidity and mortality. Methods that have proved their effectiveness on pain and mobilization used in postoperative cardiac surgery are: anti-inflammatory drugs (NSAIDs) and / or loco-regional analgesia techniques. NSAIDs enhance analgesia produced by PCA Morphine and allow a reduction in morphine consumption, improved postoperative pain, decreased sedation and decreased postoperative morbidity and mortality. Adverse effects of NSAIDs are commensurate with their time and exposure dose. Consequently, NSAIDs, in the absence of against-indications, should always be prescribed and used at the lowest effective dose and for the shortest possible time. Some studies have suggested that lower doses of NSAIDs didn't appear to affect their effectiveness. At present, the investigators have no studies that address the hypothesis from which minimum dose of ketoprofen analgesic effect is obtained. The investigators hypothesis is that lower dose ketoprofen may have efficacy on pain in the postoperative mobilization of cardiac surgery. The investigators want to find, in their study, this "optimal" ketoprofen dose which would be the minimum dose for clinical efficacy demonstrated dose. This optimal dose could reduce the number of adverse effects of NSAIDs, but their study will probably not have enough power to prove it. NSAID use at these low doses, in postoperative cardiac surgery, could be extended to patient populations most at risk or for a duration longer than 48 hours.
Detailed Description
To answer this hypothesis the investigators will consider starting a study of four groups of patients where appropriate doses to patient weight gradually increasing ketoprofen will be used in seeking the minimum effective dose. Four groups will be determined by randomization. In all these groups, analgesia will be supplemented by a systematic standard self-administered treatment with morphine and paracetamol. Group 1 : Placebo group (P). 0 mg/kg ketoprofen IV every 6 hours for 48 hours (or 0 mg/kg every 24 hours) for 48 hours. Group 2 : "Ketoprofen quarter dose" (K ¼). 0,125 mg/kg ketoprofen IV every 6 hours (0,5 mg/kg every 24 hours) for 48 hours. Group 3 : "Ketoprofen half-dose" (K ½). 0,25 mg/kg ketoprofen IV every 6 hours (1 mg/kg every 24 hours) for 48 hours. Group 4 : "Ketoprofen full dose" (KPD). 0,5 mg/kg ketoprofen IV every 6 hours (or 2 mg/kg every 24 hours) for 48 hours.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiac Surgery, Post-operative Pain
Keywords
Cardiac surgery, Post-operative pain, Kétoprofène, Minimum analgesic dose, Morphin consumption, Morphin secondary effects, Patient comfort and satisfaction, Renal fonction

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
placebo group
Arm Type
Placebo Comparator
Arm Description
Group 1 : Placebo group (P). 0 mg/kg ketoprofen IV every 6 hours for 48 hours (or 0 mg/kg every 24 hours) for 48 hours
Arm Title
ketopofen quarter dose
Arm Type
Other
Arm Description
Group 2 : "Ketoprofen quarter dose" (K ¼). 0,125 mg/kg ketoprofen IV every 6 hours (0,5 mg/kg every 24 hours) for 48 hours.
Arm Title
ketoprofen half-dose
Arm Type
Other
Arm Description
Group 3 : "Ketoprofen half-dose" (K ½). 0,25 mg/kg ketoprofen IV every 6 hours (1 mg/kg every 24 hours) for 48 hours.
Arm Title
Ketoprofen full dose
Arm Type
Other
Arm Description
Group 4 : "Ketoprofen full dose" (KPD). 0,5 mg/kg ketoprofen IV every 6 hours (or 2 mg/kg every 24 hours) for 48 hours
Intervention Type
Drug
Intervention Name(s)
Ketoprofen
Primary Outcome Measure Information:
Title
Pain at the mobilization
Description
Pain at the mobilization of the first 48 hours postoperatively, measured every 4 hours by simple numerical scale or VAS (0: no pain to 10: unbearable pain)
Time Frame
At the first 48 hours postoperatively
Secondary Outcome Measure Information:
Title
Demographic criteria
Time Frame
at day 1
Title
Quantity of sufentanil administered intraoperatively
Time Frame
at day 1
Title
Pain at rest measured by Visual Analogue Scale
Description
Pain at rest measured every 4 hours from H0+4 hours to H+48 hours by Visual Analogue Scale (H0 : sedation stop time, 1 hour before waking)
Time Frame
at day 1
Title
Total morphine consumption
Time Frame
from H0 to H0+48 hours
Title
Blood gas monitoring 3 times a day
Time Frame
from H0 to H0+48 hours
Title
Time of removal of drains after surgery
Time Frame
at day 1
Title
Resumption of transit characterized by the first gas time after surgery.
Time Frame
at day 1
Title
Nausea occurrence (number of episodes) assessed every 4 hours
Time Frame
from H0 to H0 +48 hours
Title
Vomiting occurrence (number of episodes) assessed every 4 hours
Time Frame
from H0 to H0 +48 hours
Title
Effective Duration of stay in the Intensive Care Unit
Time Frame
at day 1
Title
Patient satisfaction for its first mobilization assessed by simple scale Likert
Time Frame
at H0+ 48 hours
Title
Occurrence of the following complications: Renal respiratory cardiac Neurological infectious Hemorrhagic
Time Frame
From H0 to H0+48 hours
Title
Any readmission to the intensive care unit in the two weeks following the surgery
Time Frame
at day 7

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients scheduled for a cardiac surgery (Coronary artery bypass graft, valve replacement) Age over 18 years Weight between 60 and 100 kg Absence of criteria for non-inclusion Exclusion Criteria: Age over 75 years Renal insufficiency (MDRD <60 ml / min) Hepatic Insufficiency Congestive heart failure (EF <40%) Insulin-requiring diabetes Preoperative coagulation trouble History of peptic ulcer or gastrointestinal bleeding Allergy to NSAIDs Surgery in emergency, aorta surgery, heart transplantation Peptic ulcer scalable, history of peptic ulcer or recurrent bleeding (2 or more distinct episodes of bleeding or ulceration objectified) Pregnant or lactating women Major protected
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Patrick LACARIN
Phone
04 73 75 11 95
Email
placarin@chu-clermontferrand.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Vedat ELJEZI
Organizational Affiliation
University Hospital, Clermont-Ferrand
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU de Clermont-Ferrand
City
Clermont-Ferrand
ZIP/Postal Code
63003
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Patrick LACARIN
Phone
04 73 75 11 95
Email
placarin@chu-clermontferrand.fr

12. IPD Sharing Statement

Citations:
PubMed Identifier
28934782
Citation
Eljezi V, Biboulet C, Boby H, Schoeffler P, Pereira B, Duale C. The Dose-Dependent Effects of Ketoprofen on Dynamic Pain after Open Heart Surgery. Pain Physician. 2017 Sep;20(6):509-520.
Results Reference
derived

Learn more about this trial

Reduce Nonsteroidal Antiinflammatory Drugs Doses for Analgesia After Sternotomy

We'll reach out to this number within 24 hrs